制药提价与抑制仿制药方式 472条(本栏目收费,不能显示细节,电话13136136841)
of both the brand- name drug company and 0
the generic company are aligned with each 0
other ,but not with society’s interests, 36 36
pediatric HoFN, 109, 112 112
pediatric homozygous familial 0
hypercholesterolemia. See pediatric HoFN 0
Crestor and, 108,110, 111,112 112
In re Lipitor case of, 53,56 56
pharmaceutical companies. See brand- name drug 0
companies; by individual company 0
pharmaceutical economics, 13,19 19
pharmaceutical pricing and costs, 7 7
benefits of despite high prices and regulatory abuse, 12 12
concern and protest over rising costs of at J.P. 0
Morgan Healthcare Conference (2016), 2, 4 4
Daraprim of Turing Pharmaceuticals and, 3 3
defense of rising costs at J.P. Morgan 0
Healthcare Conference (2016), 6,7 7
effect of Big Pharma’s blocking of generic competition on, 9 9
generic competition effect on brand name drugs, 7 7
increased drug prices via pay- for- delay, 38 38
Obama on rising costs of prescription medication, 5 5
overview of complexity of pharmaceutical economics, 13,19 19
pharma companies perspective on, 7 7
protests over Sovaldi pricing (hepatitis C drug,Gilead), 2 2